Showing 17,561 - 17,580 results of 27,859 for search '(( 50 ((na decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 12 men decrease ))', query time: 1.22s Refine Results
  1. 17561

    The effects of purmorphamine and Msi1 knockdown on p21<sup>CIP1,WAF1</sup> and c-Myc expression. by In-Sun Hong (284033)

    Published 2013
    “…Purmorphamine treatment decreased and increased the expression of p21<sup>CIP1,WAF1</sup> (<b>A</b>) and c-Myc (<b>B</b>), respectively. …”
  2. 17562
  3. 17563
  4. 17564
  5. 17565
  6. 17566
  7. 17567
  8. 17568
  9. 17569

    Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain by Qiru Wang (12260453)

    Published 2024
    “…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
  10. 17570
  11. 17571

    Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts by Li Liu (75607)

    Published 2012
    “…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”
  12. 17572
  13. 17573
  14. 17574
  15. 17575
  16. 17576
  17. 17577
  18. 17578
  19. 17579
  20. 17580